ClinicalTrials.gg
RecruitingNCT06766253Updated Jan 9, 2025

The Effects of GMA-TULIP, I-gel, and BlockBuster Laryngeal Mask in Laparoscopic Surgeries With Trendelenburg Position Under General Anesthesia

An interventional study of GMA-TULIP in Sore-throat, sponsored by The Second Affiliated Hospital of Chongqing Medical University. Recruiting at 1 site in China. Open to participants aged 18 Years to 80 Years. Per ClinicalTrials.gov, last updated 2025-01-09.

Primary conditionPharyngitis(the registry's first term)UnverifiedIs this wrong?The registry often attaches Pharyngitis to studies about something else, and this study's title and listed conditions do not name it. No better condition is named, so the registry's term is kept.

Sponsored by The Second Affiliated Hospital of Chongqing Medical University · Not applicable, Interventional, and Treatment

From the registry’s dates

  • Primary completion was expected by Jun 2026, 5 months ago, but the record still lists the study as recruiting.
  • Registered 4 months after the study started (first participant enrolled Aug 2024, registered Jan 2025).
  • Started Aug 2024; still recruiting 2 years 2 months later.
Phase
Not applicable
Study type
Interventional
Enrollment
195
Allocation
Randomized
Ages
18 Years to 80 Years
Sex
All
01

Study summary

This project aims to compare the application effects of traditional inflatable BlockBuster laryngeal mask, i-gel non-inflatable laryngeal mask and GMA-TULIP non-inflatable laryngeal mask in laparoscopic surgeries with trendelenburg position under general anesthesia, in order to explore which laryngeal mask is best for reducing postoperative throat pain of patients and improving patient comfort and satisfaction.

Read the detailed description

Laryngeal mask and tracheal intubation are the two most commonly used airway management methods for patients under general anesthesia. Compared with tracheal intubation, laryngeal mask has the advantages of simple insertion, less airway injury, and more stable hemodynamics. Therefore, laryngeal mask has been widely used in airway management during general anesthesia. Studies have shown that about 3 million patients in the British National Health Service system receive anesthesia surgery with different types of airway management every year, and the usage rate of laryngeal mask is higher than that of tracheal intubation, accounting for about 56.2%.

Many new laryngeal masks have been improved based on the classic laryngeal mask and applied to clinical practice. Currently, there are two main types of laryngeal masks: inflatable laryngeal masks and non-inflatable laryngeal masks. Inflatable laryngeal masks are traditional types, including BlockBuster, Superme, ProSeal, and Fastrach, which are the most widely used in clinical practice. Traditional laryngeal masks require inflation to achieve sealing of the throat opening, but inflatable laryngeal masks have drawbacks such as inconvenient insertion, higher incidence of oral and pharyngeal injury and bleeding, and a higher incidence of postoperative sore throat. According to report, the incidence of postoperative sore throat with laryngeal masks is up to 31.9%.

The non-inflatable laryngeal mask is mirrored at the throat opening and made of thermoplastic elastomer material, which achieves a gas tightness effect similar to the inflatable laryngeal mask, improves the ease of insertion, and reduces complications such as sore throat and mucosal injury and bleeding. The i-gel laryngeal mask is the most commonly used non-inflated laryngeal mask currently. A meta-analysis found that the incidence of postoperative sore throat with the i-gel laryngeal mask is 4.1%, which is significantly lower than that of inflatable laryngeal masks.

GMA-TULIP is a new type of non-inflatable laryngeal mask with advantages such as C-shaped double gastric tube channel, stable platform for tongue root, soft tissue sealing ring, epiglottis attached protrusion, and consistent with the anatomical structure of the throat. In addition, the front cuff of GMA-TULIP is small, which only needs to reach the two sides of the pyriform fossa in the distal end. During placement, it passes over the tongue root and reaches the standard position. Compared with i-gel non-inflatable laryngeal mask, GMA-TULIP is more in line with the anatomical position design, theoretically better in position, less likely to cause damage to the throat and pharynx, thus, lower incidence of postoperative sore throat.

In laparoscopic surgeries with trendelenburg position under general anesthesia, the airway pressure is significantly higher than that in the supine position and non-laparoscopic surgery, thus, the incidence of postoperative sore throat is higher than that in the supine position and non-laparoscopic surgery. Therefore, this project intends to compare the effects of traditional inflatable BlockBuster laryngeal mask, i-gel non-inflatable laryngeal mask, and GMA-TULIP non-inflatable laryngeal mask in laparoscopic surgeries with trendelenburg position, in order to explore which laryngeal mask is best for reducing postoperative throat pain of patients and improving patient comfort and satisfaction.

02

Conditions studied

  • Sore-throat

Browse trials for

03

In context

Pharyngitis Unverified

226 studies on the registry are indexed under Pharyngitis; 35 are open to participants now.

This study's planned enrollment of 195 is above the median of 144 across 188 interventional studies indexed under Pharyngitis.

Browse Pharyngitis studies →

Lead sponsor

The Second Affiliated Hospital of Chongqing Medical University is the lead sponsor of 102 studies on the registry; 32 are open to participants now.

Compared within Pharyngitis, the registry's first condition term, which may not be this study's main condition. Counted across the registry records on this site, refreshed daily. How we classify →

04

Who can participate

Ages eligible
18 Years to 80 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  1. Patients received laparoscopic surgeries with trendelenburg position and an estimated surgery duration of less than 3 hours.
  2. Ages between 18 to 80, and less than 28 kg/m².
  3. (ASA) Grades I-III.
  4. Patients are willing to participate and be able to understand and sign an form.

Exclusion criteria

Exclusion Criteria:

  1. Patients with a mouth opening less than 2 cm.
  2. Patients with risk factors for regurgitation and aspiration of gastric contents.
  3. Patients with laryngopharyngeal diseases.
  4. Patients with potentially difficult airways.
  5. Patients with hearing, intellectual, communication, and cognitive impairments.
  6. Any reason that patients could not cooperate with the study or that the researcher deems inappropriate for inclusion in this trial.
Terms in these criteria, in plain language(3)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

BMI (body mass index)

Weight in kilograms divided by height in metres squared. Example: 70 kg and 1.75 m gives 70 ÷ (1.75 × 1.75) ≈ 22.9.

What counts as overweight or obesity differs between countries (some use lower cut-offs), so go by the range the study states.

ASA physical status

The anaesthetists’ scale of health before surgery: I is healthy, II has a mild illness that is under control, III a severe one, IV a severe illness that is a constant threat to life. V and VI are used for the critically ill and for organ donors.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorised to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Double (Participant, Outcomes assessor)
Enrollment
195 participants (estimated)

Study arms

  • Experimental
    GMA-TULIP

    Using GMA-TULIP non-inflatable laryngeal mask for airway management in patients who receives laparoscopic surgeries with trendelenburg position.

    Device: GMA-TULIP

  • Active comparator
    i-gel

    Using i-gel non-inflatable laryngeal mask for airway management in patients who receives laparoscopic surgeries with trendelenburg position.

    Device: GMA-TULIP

  • Active comparator
    BlockBuster

    Using BlockBuster inflatable laryngeal mask for airway management in patients who receives laparoscopic surgeries with trendelenburg position.

    Device: GMA-TULIP

Interventions

  • DeviceGMA-TULIP

    Using GMA-TULIP non-inflatable laryngeal mask for airway management in patients who receives laparoscopic surgeries with trendelenburg position.

06

What researchers measure

Primary outcomes

  1. Incidence of postoperative sore throat

    Sore throat is assessed by Prince-Henry pain scores (0 to 4 points)

    Time frame: 10 minutes, 2 hours, 24 hours, 48 hours, and 72 hours after surgery

Secondary outcomes

  1. incidence of dysphagia

    Check the patient can swallow or not

    Time frame: 10 minutes, 2 hours, 24 hours, 48 hours, and 72 hours after surgery

Other outcomes

  1. Time of insertion

    Insertion time was defined as the time from the opening of the mouth by the operator to the positively insert the laryngeal mask. The time of glottic examination, adjustment between two ventilation insertions, and ventilation was not measured as ventilation insertion time.

    Time frame: 1 min after successful insertion of the laryngeal mask

  2. Times of laryngeal mask adjustment before the successful insertion

    The times of laryngeal mask adjustments before successful laryngeal mask insertion.

    Time frame: 1 min after the airway is successfully controlled.

  3. The rate of first-insertion success

    The first successful insertion is defined as oropharyngeal leak pressure higher than 20 cmH2O and grade 1-2 of the laryngeal view under the fibreoptic bronchoscopy (indicating the accuracy of laryngeal mask positioning) at the first attempt.

    Time frame: 1 min after the first-attempt insertion of the laryngeal mask

  4. Total insertion success rate

    The total successful insertion is defined as ventilation with the allocated laryngeal mask after anesthesia induction.

    Time frame: 1 min after the airway is successfully controlled.

  5. Success rate of gastric tube insertion through laryngeal mask

    After the laryngeal mask is successful inserted, a fully lubricated 14F gastric tube was inserted through its esophageal drainage tube

    Time frame: 1 min after the laryngeal mask is successful inserted

  6. grade of view on fibreoptic bronchoscopy

    After successful insertion of the laryngeal mask, fiberoptic bronchoscopy was used and graded according to the degree of glottic and epiglottis exposure by a 4-point scale system: 1, full view of glottis; 2, vocal cords, arytenoids, and inferior surface of epiglottis visible; 3, only superior surface of epiglottis visible; 4, no part of epiglottis or larynx visible. The grades 1 and 2 were defined as optimal fiberscopic view.

    Time frame: 1 min after successful insertion of the laryngeal mask, 5 min after pneumoperitoneum and trendelenburg position

  7. oropharyngeal leak pressure

    After the laryngeal mask is inserted, set the fresh gas flow to 3 L/min in manual mode, turn the APL valve to 30 cmH2O, and listen to the neck until the sound of air leakage is heard. The peak airway pressure at this time is the oropharyngeal leak pressure.

    Time frame: 1 min after the laryngeal mask is successfully inserted, 5 min after pneumoperitoneum and trendelenburg position

  8. Peak airway pressure

    Peak pressure refers to the maximum pressure produced by the airflow in the closed circuit each time the ventilator delivers a certain amount of gas from the endotracheal tube to the patient's lungs. Peak airway pressure was measured by the anesthesia machine automatically.

    Time frame: 1 min after the laryngeal mask is successfully inserted, 5 min after pneumoperitoneum and trendelenburg position

  9. Airway plateau pressure

    Plateau airway pressure refers to the pressure that a certain amount of gas remains in the lungs against the entire closed system at the end of the passage of air, before the beginning of exhalation. Airway plateau pressure was measured by the anesthesia machine automatically.

    Time frame: 1 min after the laryngeal mask is successfully inserted, 5 min after pneumoperitoneum and trendelenburg position

  10. heart rate

    heart rate

    Time frame: 1 min before laryngeal mask insertion or withdrawn, and 1 min after the laryngeal mask is inserted or withdrawn

  11. diastolic blood pressure

    diastolic blood pressure

    Time frame: 1 min before laryngeal mask insertion or withdrawn, and 1 min after the laryngeal mask is inserted or withdrawn

  12. systolic blood pressure

    systolic blood pressure

    Time frame: 1 min before laryngeal mask insertion or withdrawn, and 1 min after the laryngeal mask is inserted or withdrawn

  13. mean arterial pressure

    mean arterial pressure

    Time frame: 1 min before laryngeal mask insertion or withdrawn, and 1 min after the laryngeal mask is inserted or withdrawn

  14. Times of intraoperative air leakage

    intraoperative air leakage is defined as hearing an air leak in the pharynx during the operation

    Time frame: From the start of anesthesia to the end of the anesthesia

  15. Times of laryngeal mask adjustment during the operation

    the times of the laryngeal mask adjustment during the operation were recorded

    Time frame: From the start of anesthesia to the patient's exit from the operating room

  16. The incidence of aspiration

    The aspiration is defined as seeing the gastric content in the trachea

    Time frame: From the start of anesthesia to the patient's exit from the operating room

  17. The incidence of regurgitation

    The regurgitation is defined as seeing the gastric content in the mouth

    Time frame: From the start of anesthesia to the patient's exit from the operating room

  18. incidence of blood staining on the laryngeal mask

    When the laryngeal mask was pulled out, the laryngeal mask was stained with blood

    Time frame: 1 min after the laryngeal mask is pull out after surgery.

  19. The incidence of cough

    When the laryngeal mask was pulled out, record whether the patient has cough or not.

    Time frame: the time when the laryngeal mask is pull out

  20. Active mouth bleeding rate

    After the laryngeal mask was removed, record whether active bleeding occurred at the patient's mouth

    Time frame: 1 min after laryngeal mask removal

  21. Time of laryngeal mask application

    The time of laryngeal mask withdrawn minus the time of successful laryngeal mask insertion is the time of laryngeal mask application

    Time frame: 1 min after the laryngeal mask is withdrawn

  22. Length of surgery

    The end of the surgery time minus the start of the surgery time is the length of surgery

    Time frame: 1 min after the end of surgery

  23. The incidence of hoarseness

    the patient is hoarse when speaking

    Time frame: 10 minutes, 2 hours, 24 hours, 48 hours, and 72 hours after surgery

07

Study locations

1 of 1 sites recruiting
08

References and documents

Individual participant data

Plan to share: Yes — Individual participant data (IPD) will be available with the responding author when required.

Supporting information: Study protocol, Statistical analysis plan, Informed consent form, Clinical study report, Analytic code

Time frame: The data will become available when publish and keep it for 5 years.

Access criteria: Researchers who provide a methodologically sound proposal.

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jan 9, 2025, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06766253
Responsible party
Sponsor
First posted
Jan 9, 2025
Start date
Aug 21, 2024
Primary completion
Jun 1, 2026 (estimated)
Completion
Jun 1, 2026 (estimated)
Last update
Jan 9, 2025

Study contacts

Bing Chen, PhD
Contact
chenbing@cqmu.edu.cn
+8617323832352
Bing Chen
principal investigator · The Second Affiliated Hospital of Chongqing Medical University

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion